Literature DB >> 27864608

Viper Venom Botox: The Molecular Origin and Evolution of the Waglerin Peptides Used in Anti-Wrinkle Skin Cream.

Jordan Debono1, Bing Xie2, Aude Violette3, Rudy Fourmy3, Marc Jaeger4, Bryan G Fry5.   

Abstract

The molecular origin of waglerin peptides has remained enigmatic despite their industrial application in skin cream products to paralyse facial muscles and thus reduce the incidence of wrinkles. Here we show that these neurotoxic peptides are the result of de novo evolution within the prepro region of the C-type natriuretic peptide gene in Tropidolaemus venoms, at a site distinct from the domain encoding for the natriuretic peptide. It is the same region that yielded the azemiopsin peptides from Azemiops feae, indicative of a close relationship of this toxin gene between these two genera. The precursor region for the molecular evolution is a biodiversity hotspot that has yielded other novel bioactive peptides with novel activities. We detail the diversity of components in this and other species in order to explore what characteristics enable it to be such a biodiscovery treasure trove. The unusual function of Tropidolaemus venoms may have been selected for due to evolutionary pressures brought about by a high likelihood of prey escape.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27864608     DOI: 10.1007/s00239-016-9764-6

Source DB:  PubMed          Journal:  J Mol Evol        ISSN: 0022-2844            Impact factor:   2.395


  13 in total

1.  Immediate and Long-term Clinical Benefits of a Topical Treatment for Facial Lines and Wrinkles.

Authors:  Nathan S Trookman; Ronald L Rizer; Rosanne Ford; Elizabeth Ho; Vincent Gotz
Journal:  J Clin Aesthet Dermatol       Date:  2009-03

2.  From genome to "venome": molecular origin and evolution of the snake venom proteome inferred from phylogenetic analysis of toxin sequences and related body proteins.

Authors:  Bryan G Fry
Journal:  Genome Res       Date:  2005-03       Impact factor: 9.043

3.  Evolution of an arsenal: structural and functional diversification of the venom system in the advanced snakes (Caenophidia).

Authors:  Bryan G Fry; Holger Scheib; Louise van der Weerd; Bruce Young; Judith McNaughtan; S F Ryan Ramjan; Nicolas Vidal; Robert E Poelmann; Janette A Norman
Journal:  Mol Cell Proteomics       Date:  2007-09-12       Impact factor: 5.911

4.  Novel venom proteins produced by differential domain-expression strategies in beaded lizards and gila monsters (genus Heloderma).

Authors:  Bryan G Fry; Kim Roelants; Kelly Winter; Wayne C Hodgson; Laura Griesman; Hang Fai Kwok; Denis Scanlon; John Karas; Chris Shaw; Lily Wong; Janette A Norman
Journal:  Mol Biol Evol       Date:  2009-10-15       Impact factor: 16.240

5.  Waglerin-1 selectively blocks the epsilon form of the muscle nicotinic acetylcholine receptor.

Authors:  J J McArdle; T L Lentz; V Witzemann; H Schwarz; S A Weinstein; J J Schmidt
Journal:  J Pharmacol Exp Ther       Date:  1999-04       Impact factor: 4.030

6.  Differential evolution and neofunctionalization of snake venom metalloprotease domains.

Authors:  Andreas Brust; Kartik Sunagar; Eivind A B Undheim; Irina Vetter; Daryl C Yang; Dary C Yang; Nicholas R Casewell; Timothy N W Jackson; Ivan Koludarov; Paul F Alewood; Wayne C Hodgson; Richard J Lewis; Glenn F King; Agostinho Antunes; Iwan Hendrikx; Bryan G Fry
Journal:  Mol Cell Proteomics       Date:  2012-12-12       Impact factor: 5.911

7.  Structure-function studies of waglerin I, a lethal peptide from the venom of Wagler's pit viper, Trimeresurus wagleri.

Authors:  J J Schmidt; S A Weinstein
Journal:  Toxicon       Date:  1995-08       Impact factor: 3.033

8.  Molecular properties and structure-function relationships of lethal peptides from venom of Wagler's pit viper, Trimeresurus wagleri.

Authors:  J J Schmidt; S A Weinstein; L A Smith
Journal:  Toxicon       Date:  1992-09       Impact factor: 3.033

9.  Analysis of Colubroidea snake venoms by liquid chromatography with mass spectrometry: evolutionary and toxinological implications.

Authors:  Bryan G Fry; Wolfgang Wüster; Sheik Fadil Ryan Ramjan; Timothy Jackson; Paolo Martelli; R Manjunatha Kini
Journal:  Rapid Commun Mass Spectrom       Date:  2003       Impact factor: 2.419

10.  A study on the cause of death due to waglerin-I, a toxin from Trimeresurus wagleri.

Authors:  W W Lin; L A Smith; C Y Lee
Journal:  Toxicon       Date:  1995-01       Impact factor: 3.033

View more
  6 in total

1.  Evolutionary Interpretations of Nicotinic Acetylcholine Receptor Targeting Venom Effects by a Clade of Asian Viperidae Snakes.

Authors:  Richard J Harris; Christina N Zdenek; Jordan Debono; David Harrich; Bryan G Fry
Journal:  Neurotox Res       Date:  2020-05-11       Impact factor: 3.911

Review 2.  Snake Venom Peptides: Tools of Biodiscovery.

Authors:  Aisha Munawar; Syed Abid Ali; Ahmed Akrem; Christian Betzel
Journal:  Toxins (Basel)       Date:  2018-11-14       Impact factor: 4.546

3.  Dynamic genetic differentiation drives the widespread structural and functional convergent evolution of snake venom proteinaceous toxins.

Authors:  Bing Xie; Daniel Dashevsky; Darin Rokyta; Parviz Ghezellou; Behzad Fathinia; Qiong Shi; Michael K Richardson; Bryan G Fry
Journal:  BMC Biol       Date:  2022-01-07       Impact factor: 7.431

Review 4.  Drug Discovery on Natural Products: From Ion Channels to nAChRs, from Nature to Libraries, from Analytics to Assays.

Authors:  Reka A Otvos; Kristina B M Still; Govert W Somsen; August B Smit; Jeroen Kool
Journal:  SLAS Discov       Date:  2019-01-25       Impact factor: 3.341

5.  A Taxon-Specific and High-Throughput Method for Measuring Ligand Binding to Nicotinic Acetylcholine Receptors.

Authors:  Christina N Zdenek; Richard J Harris; Sanjaya Kuruppu; Nicholas J Youngman; James S Dobson; Jordan Debono; Muzaffar Khan; Ian Smith; Mike Yarski; David Harrich; Charlotte Sweeney; Nathan Dunstan; Luke Allen; Bryan G Fry
Journal:  Toxins (Basel)       Date:  2019-10-16       Impact factor: 4.546

6.  Stingray Venom Proteins: Mechanisms of Action Revealed Using a Novel Network Pharmacology Approach.

Authors:  Kim N Kirchhoff; André Billion; Christian R Voolstra; Stephan Kremb; Thomas Wilke; Andreas Vilcinskas
Journal:  Mar Drugs       Date:  2021-12-24       Impact factor: 5.118

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.